Cargando…
Changes in Plasma VEGF and PEDF Levels in Patients with Central Serous Chorioretinopathy
Background and Objectives: Retinal pigment epitheliopathy and hyperpermeability of choroidal vessels were postulated to be involved in the pathogenesis of central serous chorioretinopathy (CSC). Imbalanced levels of vascular endothelial growth factor (VEGF) and pigment-epithelium–derived factor (PED...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540423/ https://www.ncbi.nlm.nih.gov/pubmed/34684100 http://dx.doi.org/10.3390/medicina57101063 |
_version_ | 1784588983459643392 |
---|---|
author | Chrząszcz, Michał Pociej-Marciak, Weronika Żuber-Łaskawiec, Katarzyna Romanowska-Dixon, Bożena Sanak, Marek Michalska-Małecka, Katarzyna Petrovič, Mojca Globočnik Karska-Basta, Izabella |
author_facet | Chrząszcz, Michał Pociej-Marciak, Weronika Żuber-Łaskawiec, Katarzyna Romanowska-Dixon, Bożena Sanak, Marek Michalska-Małecka, Katarzyna Petrovič, Mojca Globočnik Karska-Basta, Izabella |
author_sort | Chrząszcz, Michał |
collection | PubMed |
description | Background and Objectives: Retinal pigment epitheliopathy and hyperpermeability of choroidal vessels were postulated to be involved in the pathogenesis of central serous chorioretinopathy (CSC). Imbalanced levels of vascular endothelial growth factor (VEGF) and pigment-epithelium–derived factor (PEDF) were previously implicated in the development of chorioretinal diseases characterized by increased vascular permeability. We aimed to compare the plasma levels of proangiogenic VEGF and antiangiogenic PEDF for 26 patients with acute CSC, 26 patients with chronic CSC, and 19 controls. Materials and Methods: VEGF and PEDF levels were measured using a multiplex immunoassay or enzyme-linked immunosorbent assay. Correlations with disease duration were assessed. Results: VEGF levels differed between groups (p = 0.001). They were lower in patients with acute CSC (p = 0.042) and chronic CSC (p = 0.018) than in controls. PEDF levels were similar in all groups. The VEGF-to-PEDF ratio was lower in CSC patients than in controls (p = 0.04). A negative correlation with disease duration was noted only for PEDF levels in the group with chronic CSC (rho = −0.46, p = 0.017). Discussion: Our study confirmed that patients with CSC have imbalanced levels of VEGF and PEDF. This finding may have important implications for the pathogenesis of CSC. VEGF-independent arteriogenesis rather than angiogenesis may underlie vascular abnormalities in these patients. |
format | Online Article Text |
id | pubmed-8540423 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85404232021-10-24 Changes in Plasma VEGF and PEDF Levels in Patients with Central Serous Chorioretinopathy Chrząszcz, Michał Pociej-Marciak, Weronika Żuber-Łaskawiec, Katarzyna Romanowska-Dixon, Bożena Sanak, Marek Michalska-Małecka, Katarzyna Petrovič, Mojca Globočnik Karska-Basta, Izabella Medicina (Kaunas) Article Background and Objectives: Retinal pigment epitheliopathy and hyperpermeability of choroidal vessels were postulated to be involved in the pathogenesis of central serous chorioretinopathy (CSC). Imbalanced levels of vascular endothelial growth factor (VEGF) and pigment-epithelium–derived factor (PEDF) were previously implicated in the development of chorioretinal diseases characterized by increased vascular permeability. We aimed to compare the plasma levels of proangiogenic VEGF and antiangiogenic PEDF for 26 patients with acute CSC, 26 patients with chronic CSC, and 19 controls. Materials and Methods: VEGF and PEDF levels were measured using a multiplex immunoassay or enzyme-linked immunosorbent assay. Correlations with disease duration were assessed. Results: VEGF levels differed between groups (p = 0.001). They were lower in patients with acute CSC (p = 0.042) and chronic CSC (p = 0.018) than in controls. PEDF levels were similar in all groups. The VEGF-to-PEDF ratio was lower in CSC patients than in controls (p = 0.04). A negative correlation with disease duration was noted only for PEDF levels in the group with chronic CSC (rho = −0.46, p = 0.017). Discussion: Our study confirmed that patients with CSC have imbalanced levels of VEGF and PEDF. This finding may have important implications for the pathogenesis of CSC. VEGF-independent arteriogenesis rather than angiogenesis may underlie vascular abnormalities in these patients. MDPI 2021-10-05 /pmc/articles/PMC8540423/ /pubmed/34684100 http://dx.doi.org/10.3390/medicina57101063 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Chrząszcz, Michał Pociej-Marciak, Weronika Żuber-Łaskawiec, Katarzyna Romanowska-Dixon, Bożena Sanak, Marek Michalska-Małecka, Katarzyna Petrovič, Mojca Globočnik Karska-Basta, Izabella Changes in Plasma VEGF and PEDF Levels in Patients with Central Serous Chorioretinopathy |
title | Changes in Plasma VEGF and PEDF Levels in Patients with Central Serous Chorioretinopathy |
title_full | Changes in Plasma VEGF and PEDF Levels in Patients with Central Serous Chorioretinopathy |
title_fullStr | Changes in Plasma VEGF and PEDF Levels in Patients with Central Serous Chorioretinopathy |
title_full_unstemmed | Changes in Plasma VEGF and PEDF Levels in Patients with Central Serous Chorioretinopathy |
title_short | Changes in Plasma VEGF and PEDF Levels in Patients with Central Serous Chorioretinopathy |
title_sort | changes in plasma vegf and pedf levels in patients with central serous chorioretinopathy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540423/ https://www.ncbi.nlm.nih.gov/pubmed/34684100 http://dx.doi.org/10.3390/medicina57101063 |
work_keys_str_mv | AT chrzaszczmichał changesinplasmavegfandpedflevelsinpatientswithcentralserouschorioretinopathy AT pociejmarciakweronika changesinplasmavegfandpedflevelsinpatientswithcentralserouschorioretinopathy AT zuberłaskawieckatarzyna changesinplasmavegfandpedflevelsinpatientswithcentralserouschorioretinopathy AT romanowskadixonbozena changesinplasmavegfandpedflevelsinpatientswithcentralserouschorioretinopathy AT sanakmarek changesinplasmavegfandpedflevelsinpatientswithcentralserouschorioretinopathy AT michalskamałeckakatarzyna changesinplasmavegfandpedflevelsinpatientswithcentralserouschorioretinopathy AT petrovicmojcaglobocnik changesinplasmavegfandpedflevelsinpatientswithcentralserouschorioretinopathy AT karskabastaizabella changesinplasmavegfandpedflevelsinpatientswithcentralserouschorioretinopathy |